tirzepatide death In patients with heart failure with preserved ejection fraction and obesity, treatment with led to a lower risk of from cardiovascular causes or worsening heart-failure events than placebo. Full SUMMIT What Is Tirzepatide Used for?
Description
Los agonistas de los receptores GLP-1 y GIP son tratamientos innovadores desarrollados inicialmente para la diabetes, pero que ahora se utilizan para tratar la obesidad
GLP-1 medications are reshaping how America eats
Continue in comments #obesity #GLP1RA
:format(webp))
These headwinds have led to a sharp decline in its stock price, raising questions about the long-term impact of its gamble.
